Publication | Open Access
6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro protease activities
36
Citations
12
References
2020
Year
A repurposed drug that targets an essential enzymatic activity of SARS-CoV-2 represents a promising COVID-19 therapeutic.
| Year | Citations | |
|---|---|---|
Page 1
Page 1